Europe — EMA

Panzilan (Pantoprazole)

Pantoprazole, the active ingredient in Panzilan, is a proton pump inhibitor presented as a unknown strength/unknown form for oral use.

Pantoprazole

Request sourcing

Pack/s

What is Pantoprazole?

Pantoprazole, the active ingredient in Panzilan, is a proton pump inhibitor presented as a unknown strength/unknown form for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults. GNH USA supplies Panzilan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Panzilan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Pantoprazole used for?

Panzilan is a proton pump inhibitor that acts on the gastric acid secretion pathway.

- Gastro‑esophageal reflux disease (GERD): Improves symptom relief and promotes healing of the oesophageal lining. - Erosive esophagitis: Facilitates the ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... - Peptide ... ... ... ... ... ... ... - ... - ... - ...

What are the side effects of Pantoprazole?

Common g ... ...

What precautions apply to Pantoprazole?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →